From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Finding your Feet with Parkinson's has been designed to use the power of sport and judo to support people living with the ...

Ozzy Osbourne has been battling a rare form of Parkinson's Disease known as Parkin 2. In 2020, he disclosed to his fans that ...

Nearly 90,000 people in the United States are diagnosed with Parkinson’s Disease each year. Parkinson’s is a ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...

Tyaisha Blount-Dillon dealt with symptoms of Parkinson's for most of her life but she didn't get a life-changing diagnosis of Parkinson’s disease until her ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...